Prospective association between food protein-induced allergic proctocolitis in infancy and constipation after age 3

Michael Marget1,2, Corey Baker3, Isabel O'Connell1,2

  • 1Food Allergy Center, Massachusetts General Hospital, Boston, Massachusetts, USA.

Insights

Infant food protein-induced allergic proctocolitis (FPIAP) is linked to a higher risk of developing constipation in childhood. This study suggests a potential connection between early allergic reactions and later gastrointestinal issues.

Area of Science:

  • Pediatric Gastroenterology
  • Allergy Immunology
  • Microbiome Research

Background:

  • Food protein-induced allergic proctocolitis (FPIAP) is an allergic condition in infants.
  • Constipation is a common pediatric gastrointestinal issue.
  • The long-term effects of FPIAP on childhood gut health are not fully understood.

Purpose of the Study:

  • To prospectively investigate the association between FPIAP in infancy and the development of constipation later in childhood.
  • To explore potential shared underlying mechanisms, such as visceral hypersensitivity or intestinal dysbiosis.

Main Methods:

  • Utilized the Gastrointestinal Microbiome and Allergic Proctocolitis (GMAP) cohort data.
  • Reviewed medical charts of 375 children with prospective parent-reported constipation after age 3.
  • Confirmed FPIAP diagnosis based on pediatrician assessment and presence of bloody stools.

Main Results:

  • Children with a history of FPIAP had over double the odds of developing constipation after age 3 (OR: 2.62, p=0.002).
  • The incidence of stimulant laxative use was significantly higher in children with FPIAP (OR: 4.68, p=0.01).

Conclusions:

  • FPIAP during infancy is prospectively associated with an increased risk of constipation in later childhood.
  • This association may indicate shared underlying pathogenesis, potentially involving heightened visceral hypersensitivity or intestinal dysbiosis.
  • Further research is warranted to elucidate the mechanisms connecting FPIAP and childhood constipation.

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
317
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
134
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
388
Assessment of the Rectum and Anus01:25

Assessment of the Rectum and Anus

Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
157
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
247
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
138